PMH4 AN INDIRECT TREATMENT COMPARISON OF BREXPIPRAZOLE VERSUS LURASIDONE IN PATIENTS UNDERGOING ACUTE AND MAINTENANCE PHASE TREATMENT FOR SCHIZOPHRENIA

Autor:	K. Maman, T. Krause, M. Bøg, P. Shukla, A.M. Pedersen, S.R. Meehan, S. Takyar
Rok vydání:	2019
Předmět:	medicine.medical_specialty business.industry Health Policy Public Health Environmental and Occupational Health medicine.disease chemistry.chemical_compound chemistry Schizophrenia Indirect Treatment Internal medicine Medicine Maintenance phase In patient business Lurasidone medicine.drug Brexpiprazole
Zdroj:	Value in Health. 22:S226
ISSN:	1098-3015
DOI:	10.1016/j.jval.2019.04.1050
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::26797d331fdfbc610c970678fa5c04c8 https://doi.org/10.1016/j.jval.2019.04.1050 Zobrazit plný text záznamu Full Text from ScienceDirect